Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Nordic Adjuvant IFN Melanoma Trial

This study has been completed.
Sponsor:
Collaborator:
Merck Sharp & Dohme Corp.
Information provided by:
Karolinska Institutet
ClinicalTrials.gov Identifier:
NCT01259934
First received: December 10, 2010
Last updated: December 13, 2010
Last verified: December 2010